Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)

NCT01896973 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopped due to business decision

Conditions

Benign Prostatic Hyperplasia (BPH)

Interventions

DEVICE: Vortx Rx - Histotripsy BPH Device

Sponsor

HistoSonics, Inc.